Gene: Auts2 (autism susceptibility candidate 2)
Rattus norvegicus |
| Symbol: |
Auts2
|
| Name: |
autism susceptibility candidate 2
|
| Description: |
INTERACTS WITH 17beta-estradiol; phenylephrine; arsenic atom (ortholog) |
| Type: |
protein-coding
|
| Also known as: |
autism susceptibility candidate 2; autism susceptibility candidate 2 (predicted); autism susceptibility candidate 2-like; autism susceptibility gene 2 protein; auts2_predicted; Auts2_predicted; Auts2l; LOC304419
|
| Allele / Splice: |
Auts2Tn(sb-T2/Bart3)2.344Mcwi
|
| Latest Assembly: |
RGSC Genome Assembly v3.4
|
| NCBI Annotation Information: |
Genome Annotation Status: not on current assembly |
| Position: |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 12 | q12 | | NCBI | RGSC Genome Assembly v3.4 | 12 | 25,518,248 - 25,541,023 | + | NCBI | Rat Celera Assembly | 12 | 26,125,865 - 26,331,152 | + | NCBI | Genome Assembly 3.1 | 12 | 25,934,719 - 26,030,511 | + | NCBI |
|
| Model |
|
|
 Gene-Chemical Interaction Annotations
References - curated Genomics
Position Markers
| D12Mgh3 |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 12 | q12 | | UniSTS | RGSC Genome Assembly v5.0 | 12 | 29,257,552 - 29,257,669 | | UniSTS | RGSC Genome Assembly v3.4 | 12 | 25,271,824 - 25,271,941 | | UniSTS | RGSC Genome Assembly v3.4 | 12 | 25,271,823 - 25,271,941 | | RGD | Rat Celera Assembly | 12 | 25,971,194 - 25,971,311 | | UniSTS | Genome Assembly 3.1 | 12 | 25,134,969 - 25,135,323 | | RGD | RH 3.4 | 12 | 405.5 | | RGD | RH 3.4 | 12 | 405.5 | | UniSTS | RH 2.0 | 12 | 285.3 | | RGD |
|
| D12Rat23 |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 12 | q12 | | UniSTS | RGSC Genome Assembly v5.0 | 12 | 29,163,046 - 29,163,190 | | UniSTS | RGSC Genome Assembly v3.4 | 12 | 25,367,107 - 25,367,251 | | UniSTS | RGSC Genome Assembly v3.4 | 12 | 25,367,106 - 25,367,251 | | RGD | Rat Celera Assembly | 12 | 25,875,595 - 25,875,739 | | UniSTS | Genome Assembly 3.1 | 12 | 25,230,197 - 25,230,561 | | RGD | SHRSP x BN | 12 | 27.31 | | RGD | SHRSP x BN | 12 | 27.31 | | UniSTS | FHH x ACI | 12 | 11.22 | | RGD |
|
| D5Mit324 |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 12 | q12 | | UniSTS | RGSC Genome Assembly v3.4 | 12 | 25,399,377 - 25,399,502 | | UniSTS |
|
| RH143225 |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 12 | q12 | | UniSTS | RGSC Genome Assembly v5.0 | 12 | 29,386,758 - 29,386,891 | | UniSTS | RGSC Genome Assembly v3.4 | 12 | 25,142,798 - 25,142,931 | | UniSTS | Rat Celera Assembly | 12 | 26,100,088 - 26,100,221 | | UniSTS | RH 3.4 | 12 | 403.91 | | UniSTS |
|
| RH144305 |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 12 | q12 | | UniSTS | RGSC Genome Assembly v5.0 | 12 | 29,313,357 - 29,313,458 | | UniSTS | RGSC Genome Assembly v3.4 | 12 | 25,216,174 - 25,216,275 | | UniSTS | Rat Celera Assembly | 12 | 26,026,999 - 26,027,100 | | UniSTS | RH 3.4 | 12 | 403.21 | | UniSTS |
|
| BE108855 |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 12 | q12 | | UniSTS | RGSC Genome Assembly v5.0 | 12 | 29,204,803 - 29,204,965 | | UniSTS | RGSC Genome Assembly v3.4 | 12 | 25,325,108 - 25,325,270 | | UniSTS | Rat Celera Assembly | 12 | 25,917,724 - 25,917,886 | | UniSTS | RH 3.4 | 12 | 423.5 | | UniSTS |
|
| RH140050 |
| Map | Chr | Position | Strand | Source |
|---|
Rat Cytogenetic Map | 12 | q12 | | UniSTS | RGSC Genome Assembly v5.0 | 12 | 29,153,308 - 29,153,492 | | UniSTS | RGSC Genome Assembly v3.4 | 12 | 25,377,728 - 25,377,912 | | UniSTS | Rat Celera Assembly | 12 | 25,865,220 - 25,865,404 | | UniSTS | RH 3.4 | 12 | 403.01 | | UniSTS |
|
QTLs in Region (RGSC Genome Assembly v3.4)
| 6893681 | Bw109 | Body weight QTL 109 | 2.3 | .004 | Body weight | salt-loaded | 12 | 1 | 25938641 | Rat | | 61331 | Eau2 | Experimental allergic uveoretinitis QTL 2 | | .0005 | Uvea inflammation score | | 12 | 1 | 29130348 | Rat | | 1598855 | Bp294 | Blood pressure QTL 294 | 3.5 | | Blood pressure | systolic | 12 | 1 | 35270263 | Rat | | 2303575 | Insul14 | Insulin level QTL 14 | 4 | | Insulin level | | 12 | 1 | 43562201 | Rat | | 737979 | Pia22 | Pristane induced arthritis QTL 22 | 4.1 | | Joint/bone inflammation | arthritis severity | 12 | 530865 | 45530865 | Rat | | 61416 | Pia4 | Pristane induced arthritis QTL 4 | 8.4 | | Joint/bone inflammation | number of affected paws | 12 | 568621 | 45568621 | Rat | | 634351 | Apr5 | Acute phase response QTL 5 | 6.7 | | IL-6 level | pristane induced | 12 | 568621 | 45568621 | Rat | | 2302042 | Pia38 | Pristane induced arthritis QTL 38 | 3.5 | .001 | Joint/bone inflammation | pristane induced | 12 | 568621 | 45568621 | Rat | | 634350 | Apr4 | Acute phase response QTL 4 | 6 | | Alpha1 acid glycoprotein level | pristane induced | 12 | 2248421 | 46782294 | Rat | | 61421 | Cia12 | Collagen induced arthritis QTL 12 | 4.6 | | Joint/bone inflammation | type II collagen induced | 12 | 7148164 | 36894750 | Rat | | 1600391 | Edcs2 | Endometrial carcinoma susceptibility QTL2 | 3.5 | .01 | Endometrial tumor susceptibility | | 12 | 7382953 | 27853771 | Rat | | 1302792 | Scl21 | Serum cholesterol QTL 21 | 3.8 | .0011 | Lipid level | cholesterol | 12 | 7754826 | 25802539 | Rat | | 2293086 | Iddm30 | Insulin dependent diabetes mellitus QTL 30 | 3.42 | | Glucose level | insulin-dependent | 12 | 8901318 | 29369703 | Rat | | 1300157 | Rf21 | Renal function QTL 21 | 4.42 | | Renal function | salt-loaded renal blood flow | 12 | 9628802 | 33216334 | Rat | | 1549829 | Scl48 | Serum cholesterol level QTL 48 | 5 | | Lipid level | baseline serum cholesterol | 12 | 10716230 | 46782294 | Rat | | 1331755 | Bp219 | Blood pressure QTL 219 | 3.041 | | Blood pressure | mean arterial | 12 | 11416955 | 29130304 | Rat | | 1331761 | Bp218 | Blood pressure QTL 218 | 2.973 | | Blood pressure | mean arterial | 12 | 11416955 | 46782294 | Rat | | 2293699 | Bss49 | Bone structure and strength QTL 49 | 5.61 | .0001 | Bone structure | | 12 | 11612769 | 46782294 | Rat | | 2300186 | Bmd59 | Bone mineral density QTL 59 | 7.1 | .0001 | Bone mineral density | | 12 | 11612769 | 46782294 | Rat | | 61404 | Bw120 | Body weight QTL 120 | 5.1 | | Body weight | body mass index | 12 | 12770194 | 42387195 | Rat | | 1641928 | Alcrsp5 | Alcohol response QTL 5 | | | Alcohol response | loss of righting reflex | 12 | 13948769 | 46782294 | Rat | | 2303569 | Gluco44 | Glucose level QTL 44 | 2 | | Glucose level | fasting | 12 | 13948769 | 46782294 | Rat | | 2302060 | Pia37 | Pristane induced arthritis QTL 37 | 6.1 | .001 | Joint/bone inflammation | pristane induced | 12 | 14334630 | 46782294 | Rat | | 1549902 | Bp269 | Blood pressure QTL 269 | | | Blood pressure | diastolic, daytime | 12 | 14356765 | 46782294 | Rat | | 1549912 | Bp268 | Blood pressure QTL 268 | | | Blood pressure | diastolic, daytime | 10 | 14356765 | 46782294 | Rat | | 2293684 | Bmd26 | Bone mineral density QTL 26 | 4.4 | .0002 | Bone mineral density | | 12 | 16387455 | 34112949 | Rat | | 631543 | Bp83 | Blood pressure QTL 83 | 5.8 | | Blood pressure | systolic | 12 | 16535858 | 39626712 | Rat | | 70213 | Niddm27 | Non-insulin dependent diabetes mellitus QTL 27 | 3.72 | | Glucose level | fasting | 12 | 18937438 | 39323046 | Rat | | 631560 | Apr1 | Acute phase response QTL 1 | 6.1 | | Alpha1 acid glycoprotein level | pristane induced | 12 | 20418353 | 46782294 | Rat | | 1298081 | Cia25 | Collagen induced arthritis QTL 25 | 4.7 | | Joint/bone inflammation | arthritis severity | 12 | 20932555 | 36894750 | Rat | | 737822 | Alc10 | Alcohol consumption QTL 10 | 2.2 | | Consumption level | alcohol preference | 12 | 20932559 | 41447890 | Rat | | 5684888 | Pia42 | Pristane induced arthritis QTL 42 | | | Joint/bone inflammation | pristane induced | 12 | 20932559 | 43863270 | Rat | | 1331763 | Wbc2 | White blood cell count QTL 2 | 3.162 | | White blood cell count | | 12 | 25271823 | 32988661 | Rat | | 70169 | Eae13 | Experimental allergic encephalomyelitis QTL 13 | | .032 | Brain/spinal cord inflammation | demyelination | 12 | 25367251 | 37906389 | Rat | |
